ABSTRACT
Objectives@#The aim of this study was to evaluate the profile of patients on antiresorptive therapies for cancer treatment and assess presence of oral lesions, oral hygiene status, and knowledge regarding medication-related osteonecrosis of the jaw (MRONJ). @*Materials and Methods@#This was an observational cross-sectional study that evaluated patients treated with antiresorptive medication at a single cancer hospital. Clinical data were collected and oral examination was performed to assess patient oral health. @*Results@#From July 2017 to December 2018, 90 patients were assessed; 64 were female and 26 were male, and the mean age was 61 years. The most common drug was an intravenous bisphosphonate, zoledronic acid. Among the 90 patients, 47 presented with some type of oral disease, isolated or associated. Among these 47 patients, 9 patients (10%) developed osteonecrosis. Oral hygiene was evaluated, and most patients, with or without MRONJ, presented with regular to poor condition. Regarding patient knowledge of the risks of MRONJ and the risks associated with dental surgery, 60% stated that they were not aware of the risks. @*Conclusion@#Identifying the profile of patients and their needs facilitates not only the preventive process, but also the emergence of new therapeutic options. Our study shows that most patients are weakened both by metastatic disease and antineoplastic treatment as well as by issues associated with aging because most were over 60 years of age. Collectively, this information should be considered for management of preventive and therapeutic measures.
ABSTRACT
Introdução: O câncer de boca é o 6º tipo mais frequente deneoplasia maligna no mundo. Sabe-se que o maior fator de riscoassociado a essa doença é o tabagismo. Objetivo: Relatar aexperiência de 19 anos de campanhas de prevenção de câncerde boca e tabagismo. Método: No período de 1989 a 2007 foramrealizadas campanhas de prevenção ao câncer de boca naregião central da cidade de Curitiba / PR - Brasil. Adicionalmenteao exame clínico intra-oral, os pacientes responderam a umquestionário com informações sócio-econômicas e hábitos derisco, como tabagismo e etilismo. Resultados: Foram examinadasum total de 4.405 pessoas. Foram detectadas 687 lesões oraisclassificadas como traumáticas, inflamatórias, leucoplasias,eritroplasias e malignas. Pudemos observar que porcentagem depacientes fumantes diminuiu de 22,5% em 1989 para 16,7% em2007, seguindo a tendência nacional divulgada pelo Ministério daSaúde. Os pacientes foram encaminhados para o Hospital ErastoGaertner para atendimento e conduta. Conclusão: Em 18 anosde campanha de prevenção pudemos diagnosticar precocementelesões potencialmente malignas, bem como orientar a populaçãosobre os fatores de risco em especial o tabaco. As campanhasde prevenção são um importante instrumento de diagnósticoprecoce para melhorar os indices de morbidade e mortalidade docâncer de boca.
Introduction: Oral cancer is the 6º most frequent type of cancerin the world, and one of the main causes is smoking habits.Objective: Report our 18 years experience on oral cancerprevention and tabagism. Method: We examinated people inthe streets of Curitiba / PR-Brazil, between 1989 and 2007, fororal lesions. In addition to the clinical exam, patients filled outa thorough form with social and economic information and alsoharmful habits, such as smoking and alcohol drinking. Results:4.405 people were examinated. We diagnosed 687 oral lesions(traumatic, inflammatory, leukopakia, erythroplakia, malignancysuggestivelesions). Total average of smoking patients was22.5% on 1989 and 16.7% on 2007, following the national trend,as reported by the Ministry of Health. All patients presentingoral lesions were sent to Hospital Erasto Gaertner in Curitiba.Conclusion: During 18 years of prevention campaigns we wereable to early diagnose potencially malignant lesion and to orientgeneral population about risk factors for oral cancer, speciallytobacco. Oral campaigns and screening are an important tool forprevention and to improve oral cancer morbidity and mortality.